Respiratory Illnesses Surge Across Most of the US

Respiratory Illnesses Surge Across Most of the US

It’s no surprise that the prevalence of respiratory illnesses continued its upward slant in the waning days of 2023. Respiratory illness indicators surged across two-thirds of the nation, according to the latest data from the Centers for Disease Control and Prevention (CDC), particularly impacting the Midwest and Northeast, where COVID cases were prevalent. COVID hospitalizations rose by 16.7%, causing 29,000 admissions, contributing to a 10% increase in deaths. The Midwest and Northeast reported moderate to …

Read More
FDA Warns of Skin Infections After Med Spa Treatments

FDA Warns of Skin Infections After Med Spa Treatments

A recent Food and Drug Administration (FDA) warning cautioned consumers and medical professionals about adverse events associated with injection lipolysis—a series of injections meant to break down fat cells in the areas around the injection sites. They are often delivered in spa-type settings as cosmetic procedures. The agency said the applications are sold online under the names Aqualyx, Lipodissolve, Lipo Lab, and Kabelline and are not FDA-approved treatments. Side effects include permanent scars, serious infections, …

Read More
If One Spouse Has Hypertension, The Other Spouse May Have It Too

If One Spouse Has Hypertension, The Other Spouse May Have It Too

A recent study compared the concordance of hypertension within heterosexual couples and found that in as many as 47% of all hypertension cases, when one spouse has hypertension, so  does the other spouse. Within the 4 countries studied, researchers observed a high overall prevalence of hypertension, ranging from 40% to 65% for both wives and husbands separately. At the same time, they observed a high prevalence of spousal concordant hypertension, ranging from 20% to more …

Read More
Study Shows Doxy PEP Did Not Reduce STIs

Study Shows Doxy PEP Did Not Reduce STIs

A study published in the New England Journal of Medicine represents the first clinical trial to test whether doxycycline postexposure prophylaxis (PEP) would prevent sexually transmitted infections (STIs) among cisgender women. Researchers considered 224 subjects assigned to a doxycycline-PEP group and 225 to a standard-care group over 12 months. A total of 109 incident STIs occurred: 50 in the doxycycline-PEP group and 59 in the standard-care group. Chlamydia accounted for 85 of the STIs (78%) with 35 …

Read More
Rural Residents More Likely to Seek Emergency Migraine Treatment

Rural Residents More Likely to Seek Emergency Migraine Treatment

Rural patients were more likely to present at the emergency department (ED) for migraine than those who live in non-rural areas, an epidemiologic study of  810,388 visits showed. Rural patients were more likely to receive opioid analgesics in the ED as well. Med Page Today reported on the study results from the American Society of Health-System Pharmacists midyear meeting. In rural areas in 2019, the rate of ED utilization for migraine was 41.8 per 10,000 …

Read More
ET3 Program Ends After Low Participation, Clunky Logistics

ET3 Program Ends After Low Participation, Clunky Logistics

The Centers for Medicare and Medicaid Services (CMS) announced that on December 31, 2023, it would end its 5-year pilot of the Emergency Triage, Treat And Transport program known as “ET3.” ET3 enabled ambulance service providers to transport a patient to an alternative destination and/or provide treatment on the scene by paramedics or via telemedicine. CMS is ending the program because of disappointing participation and intervention numbers. According to CMS data, there were 151 total …

Read More
Patients Less Likely to Follow Up After Telehealth Visits

Patients Less Likely to Follow Up After Telehealth Visits

Your follow-up recommendation for a patient seen with a telehealth visit is often a diagnostic test or specialty referral. Completion of those follow-up recommendations—“diagnostic loop closure”—seems to be lacking, according to a study in JAMA Network Open. The study involved 4,133 diagnostic tests and referrals (colonoscopies, cardiac stress tests, and dermatology referrals) from March 2020 through December 2021 at 2 primary care sites. Results showed that 58% of in-person visit orders were completed within the …

Read More
Statins Reduce Risks for Women Using Hormone Therapy

Statins Reduce Risks for Women Using Hormone Therapy

When physicians prescribe hormone therapy (HT) for perimenopausal women, many warn their patients of the increased risk for venous thromboembolism (VTE). However, knowing that a large number of patients also take statin medications to prevent cardiovascular issues, it would make sense to study the effect statins may have on the risk of VTE for women using HT. A new study in JAMA Network Open did that very thing and found the risk of VTE was …

Read More
Patients More Likely to Stick With Semaglutide Treatment

Patients More Likely to Stick With Semaglutide Treatment

Patients taking the GLP-1 weight loss drug semaglutide were 3 times more likely to maintain adherence to their medication regimens a year later when compared to other drug options, according to a Cleveland Clinic study. As described in Obesity, researchers examined health records of 1,911 adults in two states and found 40% of semaglutide patients were still filling their prescriptions 12 months after the initiation of treatment. Patients using other anti-obesity drugs, such as orlistat, liraglutide, …

Read More
AI Voice App Helps Optimize Insulin Dosing

AI Voice App Helps Optimize Insulin Dosing

When Alexa talks to patients with type 2 diabetes, apparently they listen.  A study in JAMA Network Open found patients gained better glycemic control when they engaged with an artificial intelligence (AI) voice app—which was customized by their respective clinicians to help them achieve optimal insulin dosing. App users demonstrated significantly better insulin adherence and glycemic improvement during the 2-month trial. Glycemic control was measured by mean fasting blood glucose, rather than HbA1c. The app …

Read More